Academic rheumatology department supporting recruitment to the clinical validation study
Involvement in the clinical validation study
No involvement
Target recruitment:
• Primary Sjögren’s syndrome – 20
• Rheumatoid Arthritis – 40
• Systemic Lupus Erythematosus – 30
• Healthy controls – 10
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.
